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The investigation of mechanical properties in molecular crystals is emerging as a
novel area of interest in crystal engineering. Indeed, good mechanical properties
are required to manufacture pharmaceutical and technologically relevant
substances into usable products. In such endeavour, bendable single crystals
help to correlate microscopic structure to macroscopic properties for potential
design. The hydrate forms of two anticonvulsant zwitterionic drugs, Pregabalin
and Gabapentin, are two examples of crystalline materials that show
macroscopic plasticity. The direct comparison of these structures with those of
their anhydrous counterparts, which are brittle, suggests that the presence of
water is critical for plasticity. In contrast, structural features such as molecular
packing and anisotropic distribution of strong and weak interactions seem less
important.
1. Introduction
In recent times, the classic idea of crystals as a brittle objects
has been progressively abandoned (Dunitz, 1984). Observa-
tion of phenomena such as shearing (Reddy et al., 2005a) or
bending (Reddy et al., 2005b) as well as martensitic (Zamir et
al., 1994; Steiner et al., 1993; Ding et al., 1991; Etter & Siedle,
1983), super-elastic (Takamizawa & Miyamoto, 2014) and
super-plastic (Takamizawa et al., 2018) transformations clearly
show that organic crystals share many similarities with metallic
and covalent inorganic analogues. Mechanical properties of
molecular crystals are investigated and discussed with
increasing frequency and those studies have attracted
considerable attention (Reddy et al., 2010; Naumov et al.,
2015). Aside from the understandable academic curiosity,
mechanical properties are important for the manufacturing of
crystalline solids into products. For example, in the pharma-
ceutical industry, good plasticity guarantees that micro-
crystalline drug substances can be readily manufactured into
tablets without the addition of excipients (Thoorens et al.,
2015; Chang & Sun, 2017).
A characteristic of molecular crystals is that they are held
together by supramolecular interactions. It follows that crystal
synthesis occurs in relatively mild conditions, whilst a supra-
molecular approach enables a certain degree of structure
design (Desiraju, 1989; Etter, 1990; Moulton & Zaworotko,
2001). In this view, understanding how molecular features
determine a crystal structure and, in turn, material properties
would enable crystal engineering and properties design.
The rapid scientific advances of the past decades allow the
confident prediction of how a given set of molecules will pack
in a crystal structure (Reilly et al., 2016). On the other hand, a
general theory is still missing to infer bulk chemical and
mechanical properties from structures. Therefore, material
development proceeds through the application of a series of
practical rules, which often apply to specific types of materials
(Lusi, 2018; Corpinot & Bučar, 2019).
The first attempts to rationalize the relationship between
structure and mechanical properties in molecular crystals
involved small aromatic molecules (Reddy et al., 2006b,a). In
such materials, aromatic stacking and halogen or hydrogen
interactions coexist in the same structure and extend along
different crystallographic axes. Manipulation of face-indexed
single crystals showed that bending occurred only perpendi-
cular to the planes of the weaker interactions, whereas the
stronger supramolecular bonds helped to preserve structural
integrity in the other directions (Saha et al., 2018). Then,
chemical anisotropy appeared as a requirement for plasticity
and such features were thought to guarantee the realization of
bendable single- and multi-component crystals (Krishna et al.,
2016; Rao Khandavilli et al., 2017; Saha & Desiraju, 2017;
Alimi et al., 2018; Nath et al., 2018). However, the discovery of
plastic bending in the (quasi)-isotropic structures of dimethyl
sulfone proves that alternative mechanisms might exist
(Thomas et al., 2017).
Due to their relevance in manufacturing and processing,
many studies of mechanical properties involve APIs (active
pharmaceutical ingredients), which suggest that hydrate forms
might have higher plasticity than their corresponding anhy-
drates (Sun & Grant, 2004; Liu et al., 2018; Fucke et al., 2012;
Chang & Sun, 2017). In these cases, the mechanical properties
were only observed at the microscopic level on polycrystalline
powders, making the correlation between structure and
properties elusive. In p-hydroxybenzoic acid (Sun & Grant,
2004) and uric acid (Liu et al., 2018), despite creating a rigid
3D hydrogen-bonded network, the inclusion of water enables
the separation of zigzag chains that are interdigitated in the
anhydrous forms (see Figs. S10 and S11 of the supporting
information). Hence, increased plasticity was explained by the
removal of a mechanical (or steric) obstacle to molecular
movement, which was deemed necessary for plastic bending.
Anhydrous theophylline shows a different story: hydrogen
bonds,  stacking and weak C O  H bonds support the
structure along the orthogonal crystallographic directions, and
there is no mechanical interlock to prevent molecular move-
ment (Fucke et al., 2012; Chang & Sun, 2017). In that view,
crystals of theophylline should be highly plastic. Instead,
plasticity is lower than in the hydrate form, which is char-
acterized by 2D hydrogen-bonded networks that pack in an
interdigitated zigzag fashion (see Fig. S12 of the supporting
information). In the theophylline system, increased plasticity
was attributed to the ‘lubricant’ action of water molecules that
allows easier slippage of the 2D sheets. Ultimately, also in the
case of hydrate forms, multiple mechanisms explain plastic
bending and the observation of such a phenomenon on single
crystals could give new insights into the role of water. This
work reports on the mechanical properties in the anhydrous
and hydrate forms of Pregabalin and Gabapentin (Fig. 1).
Despite the similar crystal packing, the hydrate forms show
superior plasticity, which results in macroscopic bending of
single crystals whereas the anhydrous forms are brittle.
2. Experimental
Pregabalin (SPG) and Gabapentin (GP) were purchased from
Flourochem. Methanol was purchased from Sigma–Aldrich
and Milli-Q water was used for the experiments.
Crystallization of SPG: SPG crystals were obtained from
commercially available SPG dissolved in methanol to satura-
tion and left at room temperature for 2 days.
Crystallization of SPGH I: SPG was dissolved in pure water
and crystallized at 280 K for 3–5 days to obtain good-quality
crystals.
Crystallization of GP and GPH: GP and its hydrate crystals
are reproduced by following the same procedure mentioned in
the literature (Wang et al., 2017; Reece & Levendis, 2008).
Optical microscopy: single crystals of SPGH I and GPH
were selected and bent with tweezers and a needle, the images
were captured using an Olympus IX53 microscope under 4
magnification.
IR spectroscopy: IR spectra for SPG and SPGH I were
collected on a PerkinElmer Spectrum 100 F T-IR Spectro-
meter equipped with a PerkinElmer Universal ATR Sampling
Accessory.
Raman spectroscopy: Raman spectra for SPG and SPGH I
were collected on a Horiba Jobin Yvon LabRam Aramis
spectrometer with a 532 nm laser source. The spectrometer
was coupled with an Olympus BX40 confocal microscope with
a CCD camera cooled by a thermoelectric Peltier device.
Raman maps were processed using the LabSPEC 5 software
package.
Powder X-ray diffraction: Powder X-ray diffraction data
were collected on an Empyrean diffractometer (PANalytical,
Philips) using Cu K1,2 radiation ( = 0.1541 nm) at room
temperature operated at 40 kV and 40 mA. The samples were
scanned over the range 4–40 2 using a step size of 0.02 2
and a scan speed of 0.02 2 s1.
Differential scanning calorimetry: calorimetric measure-
ments of SPG and SPGH I were performed on a DSC 214
Polyma, NETZSCH instrument. Typically, 3–5 mg of sample
was accurately weighed into a hermetically sealed aluminium
pan and heated to 250 C at a 10 C min1 heating rate under a
nitrogen gas flow of 40 ml min1.
Thermogravimetric analysis: Thermograms of SPG and
SPGH I were measured with a Perkin-Elmer TGA 4000
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Figure 1
Molecular structure of Pregabalin (left) and Gabapentin (right).
instrument at a heating rate of 10 C min1 under a nitrogen
stream of 20 ml min1.
X-ray crystallography: single-crystal data for SPGH I were
collected at ambient temperature using a three-circle Bruker
D8 Quest diffractometer with a sealed tube Mo anode, K
radiation = 0.71073 Å and a Photon 100 detector. Single-
crystal data for SPGH II were collected at 150 K under a
nitrogen-flow (Oxford Cryosystem) using a three-circle
Bruker D8 Quest with microfocus Cu anode, K radiation =
1.5418 Å and a Photon 100 detector.
The data were integrated and corrected for absorption with
the Bruker Apex Suite. The structure solution was obtained by
direct methods and refined against all F 2 with the SHELX
software interfaced though X-SEED (Barbour, 2001). Non-
hydrogen atoms were refined anisotropically and hydrogen
atoms were placed in calculated positions, refined using
idealized geometries (riding model) and assigned fixed
isotropic displacement parameters.
3. Results and discussion
Amino acids are an important class of biologically active
molecules that exist as zwitterionic tautomers under neutral
conditions. Among them, (S)-3-isobutyl--aminobutyric acid,
or Pregabalin (SPG), is an anticonvulsant blockbuster drug. In
the anhydrous P212121 crystal, which has the refcode CIDDEZ
(Venu et al., 2007) in the CSD (Groom et al., 2016), the
zwitterion dipoles pack along the b axis generating a double
layer that is coplanar to the (110) plane. The structure is
supported by a 2D network of charge-assisted hydrogen bonds
between the ammonium and carboxylate groups [Fig. 2(a)]. As
multiple layers stack on top of each other, the isobutyl groups
interdigitate along the [001] direction. The crystals are brittle,
as expected for mechanically interlocked structures.
Recrystallization of SPG in water at 280 K results in the
monohydrate form SPGH I. Single-crystal analysis reveals a
monoclinic C2 polar structure (Table 1). The zwitterions are
arranged along the [010] axis and are intercalated by water
molecules so that the double molecular layers separate into
parallel planes. At the same time, the molecules in each layer
come closer together preventing interdigitation [Fig. 2(b)].
SPGH I is unstable at room temperature, reverting to the
anhydrous SPG phase in air (Fig. S6). As expected from the
different crystal packing, the dehydration is associated with a
loss of macroscopic crystallinity. SPGH I undergoes a poly-
morphic transition upon cooling below 150 K. The phase
transition is reversible (enantiotropic) and occurs in a single-
crystal-to-single-crystal fashion, as demonstrated by variable-
temperature single-crystal diffraction experiments. The
packing of the low-temperature SPGH II phase is virtually
identical to the high-temperature phase. The differences are
limited to a reduced symmetry (Z0 = 16) and a different
arrangement of the hydrogen-bonded bridges with water
[Fig. 2(c)].
In molecular materials, the single-crystal-to-single-crystal
reduction of symmetry on cooling is known. Often, such
transformations assume the aspect of an order–disorder
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Table 1
Crystallographic data for SPGH I and SPGH II.
Crystal form SPGH I SPGH II
Formula C8H17NO2, H2O C8H17NO2, H2O
CCDC code 1879470 1879471
Temperature (K) 298 150
Space group C2 P21
a (Å) 9.566 (7) 9.6559 (2)
b (Å) 7.440 (6) 29.8416 (6)
c (Å) 15.911 (12) 30.1248 (7)
 () 101.54 (3) 98.540 (1)
V (Å3) 1109.5 (15) 8584.1 (3)
Z, Z0 4, 1 32, 16
 (g cm3) 1.061 1.097
	 (mm1) 0.080 0.677
R[F 2 > 2
(F 2)] (No. of reflections) 0.0586 (1721) 0.0482 (28820)
Figure 2
Schematic representation of the crystal packing of (a) SPG, (b) SPGH form I and (c) SPGH form II. Hydrogen bonding interactions are in green,
selected hydrogen atoms have been omitted for clarity.
transition, whereby a certain thermal energy is required for a
molecule to rotate or vibrate between symmetry-related
crystallographic positions (Lusi & Barbour, 2013; Braga et al.,
2018). Here, the change occurs between two fully ordered
structures instead. In that view, the preserved crystallinity is
evidence of the high plasticity of these phases, and suggests
that the supramolecular bonds with water can be easily broken
and reformed without affecting the rest of the structure.
Indeed, crystals of SPGH I exhibit plastic bending on the
application of a moment perpendicular to the c axis (Fig. 3).
Hence, the bending mechanism involves the sliding of
successive layers along the crystallographic b direction (Fig.
2). In order for this to happens, either the hydrogen bond
between water and zwitterions or the dispersion forces
between the non-polar-layer intermolecular bonds need to
quickly break and reform; crystallographic studies cannot
determine which are responsible for the bending.
GP is a molecular and pharmaceutical analogue of SPG. In
GP, cyclopentane substitutes the isobutyl group but the
supramolecular feature of the two molecules are essentially
equivalent. Due to extensive polymorph screening, multiple
anhydrous and hydrate forms of GP are reported (Braga et al.,
2008; Reece & Levendis, 2008; Wang et al., 2017).
Like SPG, the structure of GP form  (CCDC refcode
QIMKIG) is dominated by 2D networks of charge-assisted
hydrogen bonds. In the latter, the bulkier cyclopentane group
prevents interdigitation of successive layers (Fig. 4). GP
(CCDC refcode QIMKIG02) forms 1D chains (Reece &
Levendis, 2008; Wang et al., 2017; Ibers, 2001; Vasudev et al.,
2009), whereas the packing in the anhydrous  form (CCDC
refcode QIMKIG03) resembles those of the hydrate forms,
GPH I and II (CCDC refcodes QIMKOM and QIMKOM02),
and SPGH I and II, the zwitterionic groups being separated
into two planes. Remarkably, despite structural similarities,
only the hydrates undergo plastic bending, whereas all the
anhydrous forms are brittle. This observation suggests that the
intercalated water molecules, rather than the weak dispersion
forces, are responsible for the observed plastic bending.
4. Conclusions
High plasticity is a desirable property
that guarantees processability in crys-
talline drug materials. To date, different
sets of factors have been identified as
responsible for plastic crystals, but a
universal supramolecular strategy to
improve such a property is not recog-
nized yet. For example, it was suggested
that bending requires the anisotropic
hierarchical distribution of strong and
weak supramolecular interactions
along perpendicular directions. On the
other hand, interdigitation and cross-
linked hydrogen bonds (mechanical
and chemical interlocks, respectively)
have been seen as detrimental for
macroscopic plastic bending. At the
same time, an increasing number of
studies report that, at the microscopic
level, hydrated forms exhibit higher
plasticity than the anhydrous equiva-
lents. In such phases, increased plasti-
city does not seem to correlate to a
particular structural feature. This is also
true for the two zwitterionic drugs SPG
and GP. Here, plasticity occurs also at a
macroscopic level, on large single
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Figure 4
Schematic representation of the crystal packing of the (a) GP form , (b) GP form , (c) GP form ,
(d) GPH form I and (e) GPH form II. Hydrogen-bonding interactions are in green, selected
hydrogen atoms have been omitted for clarity.
Figure 3
Single crystals of SPGH I and GPH II before and after the mechanical
deformation. The larger crystal faces are indexed.
crystals, allowing a rationalization for such a phenomenon.
Limited to the investigated systems, the alternation of 2D
hydrogen-bonded networks and weak dispersive forces does
not guarantee plastic deformation in the anhydrous crystals. In
contrast, plasticity occurs in the hydrate forms even when
mechanical and chemical interlocks are present. Therefore, in
these instances the presence of water appears crucial. Many
studies highlight the structural diversity possible for water
molecules (Mascal et al., 2006; Infantes & Motherwell, 2002;
Bajpai et al., 2016). We speculate that such promiscuity,
together with the high mobility of these molecules, enables the
quick rearrangement of the supramolecular interactions that
are broken by mechanical stress.
Finally we note that SPG and GP are two examples of a
wide class of amino acids with biological activity. As sustained
by strong and directional charge-assisted hydrogen bonds, the
molecular packing of SPG and GP is common to other zwit-
terionic -aminopropionic and -aminobutyric acids. There-
fore, it would be of little surprise if those systems showed the
same properties, and the reported observations could be valid
for a wide class of drug substances.
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